Anti-CD33 [6C5/2]
Invented by Prof Paul Crocker from University of Dundee
Invented at University of Oxford
- Datasheet
- References (4)
- Inventor Info
Info
![Image thumbnail for Anti-CD33 [6C5/2]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/73d638d7-3ec1-4fe4-b97f-550f36013b27.jpg)
![Image thumbnail for Anti-CD33 [6C5/2]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/c3e29934-eb5f-4b7f-994b-ada89af1ae16.jpg)
| Catalogue Number | 151203 |
| Applications | ELISA FACS IHC |
| Antigen/Gene or Protein Targets | SIGLEC3 (CD33) |
| Synonyms | Sialic Acid Binding Ig Like Lectin 12; SIGLECL1; SLG 3; Siglec-12; Siglec-L1; S2V |
| Reactivity | Human |
| Relevance |
The SIGLECs are a family of membrane bound lectins (of the immunoglobulin superfamily) that bind sialic acid and mediate cell-cell interactions. Family members include sialoadhesin, CD22 and CD33. CD33 is found on granulocyte and macrophage precursors in the bone marrow, but not on pluripotent stem cells. CD33 is also expressed on, and a useful marker for, peripheral monocytes. CD33 is also useful for distinguishing myelogenous leukaemia cells from lymphoid or erythroid leukaemias. CD33 is a putative adhesion molecule of myelomonocytic-derived cells that mediates sialic-acid dependent binding to cells & preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. In the immune response, may act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that block signal transduction through dephosphorylation of signaling molecules. Induces apoptosis in acute myeloid leukemia (in vitro). |
| Host | Mouse |
| Immunogen | CD33-Fc recombinant protein |
| Positive Control | CD33 transfected COS cells |
| Subclass | IgG1 |
| Myeloma Used | Sp2/0-Ag14 |
| Recommended Growing Conditions | DMEM + 5% FCS |
| Research Area | Cancer, Cell Type or Organelle Marker, Immunology, Stem Cell Biology |
References: 4 entries
Souza et al. 2019. Short-Term High-Fat Diet Consumption Reduces Hypothalamic Expression of the Nicotinic Acetylcholine Receptor a7 Subunit (a7nAChR) and Affects the Anti-inflammatory Response in a Mouse Model of Sepsis Front Immunol. 10:565. PMID: 309678
Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids.
Europe PMC ID: 21931755
The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2.
Europe PMC ID: 10206955
Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules.
Europe PMC ID: 7718872
Add a reference
References: 4 entries
Souza et al. 2019. Short-Term High-Fat Diet Consumption Reduces Hypothalamic Expression of the Nicotinic Acetylcholine Receptor a7 Subunit (a7nAChR) and Affects the Anti-inflammatory Response in a Mouse Model of Sepsis Front Immunol. 10:565. PMID: 309678
Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids.
The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2.
Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules.
Add a reference
